Excell Partners
36
1M
31
2.00
5
0.11
2
- Stages of investment
- Areas of investment
Summary
In 2005 was created Excell Partners, which is appeared as VC. The main office of represented VC is situated in the Rochester. The fund was located in North America if to be more exact in United States.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Excell Partners, startups are often financed by Rand Capital, Great Oaks Venture Capital, Cayuga Venture Fund. The meaningful sponsors for the fund in investment in the same round are Cayuga Venture Fund, Rand Capital, Great Oaks Venture Capital. In the next rounds fund is usually obtained by Cayuga Venture Fund, Rand Capital, Great Oaks Venture Capital.
The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2014. Considering the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Excell Partners performs on 20 percentage points less the average number of lead investments.
Among the most popular portfolio startups of the fund, we may highlight Augmate, GiveGab. We can highlight the next thriving fund investment areas, such as Blockchain, Marketing. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups.
Investments analytics
Analytics
- Total investments
- 36
- Lead investments
- 5
- Exits
- 2
- Rounds per year
- 2.00
- Follow on index
- 0.11
- Investments by industry
- Health Care (12)
- Manufacturing (7)
- Biotechnology (6)
- Medical (5)
- Therapeutics (4) Show 49 more
- Investments by region
-
- United States (35)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 14M
- Group Appearance index
- 0.50
- Avg. company exit year
- 8
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Pharmadva | 01 Jan 2011 | Health Care, Medical Device, Medical, Pharmaceutical | Seed | 200K | United States, New York, Rochester |
Pharmapotheca A | 01 Jan 2015 | Health Care, Pharmaceutical | Seed |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.